• Nivolumab Shows More Survival Rate Compared to Chemotherapy

    8 days ago - By Medindia Health

    Randomized, phase 3 trials analyzing nivolumab with docetaxel in previously treated Non-small cell lung cancer patients showed improved survival rates in nivolumab group.
    Read more ...

     

  • Patients taking nivolumab experience five-fold increase in overall survival compared to chemotherapy

    Patients taking nivolumab experience five-fold increase in overall survival compared to chemotherapy

    8 days ago - By ScienceDaily

    Pooled data on two clinical trials demonstrate patients taking nivolumab realized a greater than five-fold increase in five-year overall survival rate compared with the chemotherapy docetaxel.
    Read more ...